Yes. Twice as much as the rest of the world in fact. Mostly due to lack of competition (25 year monopolies for simply adding a antacid to an existing drug) and zero negotiation on pricing.

The President Elect said as much yesterday.

https://www.washingtonpost.com/amphtml/news/wonk/wp/2017/01/...